IMMUNE THROMBOCYTOPENIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: CASE REPORT AND BRIEF OVERVIEW OF TREATMENT STRATEGIES
暂无分享,去创建一个
[1] S. Fuji,et al. Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[2] A. Vekhoff,et al. Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation , 2015, Bone Marrow Transplantation.
[3] M. Kurokawa,et al. Thrombopoietin/MPL signaling confers growth and survival capacity to CD41-positive cells in a mouse model of Evi1 leukemia. , 2014, Blood.
[4] W. Wiktor-Jedrzejczak,et al. Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1–risk myelodysplastic syndrome and thrombocytopenia , 2014, Cancer.
[5] E. Lanino,et al. Autoimmune hematological diseases after allogeneic hematopoietic stem cell transplantation in children: an Italian multicenter experience. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[6] U. Popat,et al. Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation. , 2013, American journal of blood research.
[7] U. Gergis,et al. Successful treatment with tacrolimus of a patient with severe idiopathic thrombocytopenic purpura after allogeneic bone marrow transplantation. , 2012, Journal of Clinical Oncology.
[8] B. Chong,et al. Romiplostim or standard of care in patients with immune thrombocytopenia. , 2010, The New England journal of medicine.
[9] J. Tolar,et al. Response of refractory immune thrombocytopenia after bone marrow transplantation to romiplostim , 2010, Pediatric blood & cancer.
[10] M. Kawahara,et al. Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome. , 2009, Blood.
[11] J. Bussel,et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial , 2009, The Lancet.
[12] H. Heuft,et al. Transfer of donor immune thrombocytopenic purpura to a recipient of an allogeneic haematopoietic stem cell graft , 2009, Bone Marrow Transplantation.
[13] P. Cernelc,et al. Splenectomy for Severe Autoimmune Cytopenias after Allogeneic Stem Cell Transplantation: Case Report , 2005, International journal of hematology.
[14] C. Craddock,et al. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation , 2005, Bone Marrow Transplantation.
[15] A. Jillella,et al. Autoimmune thrombocytopenia following autologous hematopoietic cell transplantation: review of literature and treatment options , 2000, Bone Marrow Transplantation.